Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Foretinib |
Trade Name | |
Synonyms | GSK1363089G|XL880|EXEL-2880 |
Drug Descriptions |
Foretinib (GSK1363089) is a multi-kinase inhibitor with activity against several receptor tyrosine kinases, including MET, KDR (VEGFR2), as well as ROS1 and NTRK fusions, which may result in decreased tumor angiogenesis and growth (PMID: 19808973, PMID: 26372962, PMID: 29463555, PMID: 30501104). |
DrugClasses | MET Inhibitor 59 ROS1 Inhibitor 20 TrkA Receptor Inhibitor 8 TYRO3 Inhibitor 8 VEGFR2 Inhibitor 37 |
CAS Registry Number | 849217-64-7 |
NCIT ID | C80058 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Foretinib | Foretinib | 15 | 0 |
Foretinib + PLX4720 | Foretinib PLX4720 | 0 | 0 |
Foretinib + Rucaparib | Foretinib Rucaparib | 0 | 0 |
Foretinib + Veliparib | Foretinib Veliparib | 0 | 0 |